ArticleFrontiers in public health2025
The DREAM Programme, lessons learnt from 20 years of experience.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating neurology in community healthcare in sub-Saharan Africa: experience and outcomes of the 7-year partnership between the Italian Society of Neurology and the DREAM program.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe characteristics and results from the DREAM Program, a public health program initiated in Mozambique in 2002 to fight AIDS and other chronic diseases in Sub Saharan Africa. The DREAM Program is currently implemented in 10 countries providing free-of-charges services to over 110,000 patients. DREAM achieved remarkable success in the prevention of mother to child transmission of HIV, in adherence and retention support, in viral load monitoring. Among the challenges: the limited therapeutic options for people living with HIV experiencing virological failure and limited access to resistance tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.